Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
-
* Corresponding author: Konstantinos T Papazisis kpapazisis@the.forthnet.gr
BMC Cancer 2009, 9:82 doi:10.1186/1471-2407-9-82
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 08 Oct 2008 | |
| Reviewer's Report | Torgny Rasmuson | 10 Nov 2008 | |
| Reviewer's Report | Grant McArthur | 08 Dec 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 07 Jan 2009 |
| Reviewer's Report | Torgny Rasmuson | 05 Feb 2009 | |
| Reviewer's Report | Grant McArthur | 10 Feb 2009 | |
| Editorial acceptance | 20 Feb 2009 | ||
| Published | 12 Mar 2009 |